AzTrials
AzTrials

FrailtyEngAGENCT05337514

Voice-Activated Technology to Improve Mobility in Multimorbid, Frail, Homebound Older Adults (EngAGE)

A study testing Enhanced Engagement and Standard Engagement in people with Frailty, run by University of Chicago at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to test the efficacy of EngAGE (an interactive, voice-activated app) vs usual care on improving older adult physical and social function. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Frailty
What is being tested?
Enhanced Engagement and Standard Engagement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
137 participants
Where
1 siteUnited States
Study dates
26 Oct 2022to 16 Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age greater than or equal to 60 years
  • has at least 2 chronic conditions
  • requires any assistance to leave the home (this may include requiring someone to drive, requiring the use of a cane or walker, or similar)
  • can read 14 point font from a 2-foot distance on a tablet-sized screen
  • can hear spoken voice from 2-foot distance
  • SPPB score of less than or equal to 9 but greater than 3 on a 12-point scale to target moderate but not severe functional impairment.

Who cannot join

  • reported history of moderate to advanced cognitive impairment;
  • inability to stand unassisted;
  • inability to understand English (because the intervention is currently only available in English);
  • life expectancy less than 12 months or enrolled in Hospice;
  • a medical condition making unsupervised physical activity potentially unsafe including: stroke within prior 12 months, acute myocardial infarction or unstable angina in the prior 6 months, uncontrolled arrhythmias, dissecting aortic aneurysm, acute endo/pericarditis, acute thromboembolism, acute or severe heart or respiratory failure, uncontrolled hypertension greater than 180/100, fracture or joint replacement within the prior 3 months, infections affecting one's general health condition, severe peripheral vascular disease.
  • severe functional impairment as indicated by an SPPB score less than 3 (out of 12);
  • baseline Montreal Cognitive Assessment of less than or equal to 18/30;
  • inability to understand consent (teach back).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Chicago

    Chicago, Illinois, 60637

Other trials in United States

About this study

Official title: Voice-Activated Technology to Improve Mobility in Multimorbid, Frail, Homebound Older Adults: EngAGEing Older Adult-Care Partner Dyads

The purpose of this study is to test the efficacy of EngAGE (an interactive, voice-activated app) vs usual care on improving older adult physical and social function.

Read the detailed description

Physical activity is essential for all age groups, across all comorbidities and geriatric syndromes; it has been described as the 'ideal' intervention for aging. Increasing physical activity among homebound, multimorbid, African American (AA) older adults (OAs) requires a shift in interventions to target the older adult-care partner (CP) pair (dyad) and to test innovative vehicles for remote intervention delivery. Our research goal is to create an evidence-based intervention that leverages technology to reach multimorbid OA-CP dyads in the home, promotes long-term mobility and social engagement among those least able to access community resources, and empowers informal care partners with tools. We developed a socially-motivated exercise tool for multimorbid OA-CP dyads called EngAGE that leverages voice-activated technology. We propose to conduct a 6-month, randomized, in-home trial of EngAGE (intervention) versus paper exercise handouts (usual care) in 124 multimorbid, homebound, AA OA-CP dyads recruited from 2 hospital systems and the community. Our overall hypothesis is that EngAGE will improve both physical and social function of older adults.

All OA subjects will undergo an in-home baseline visit where we will collect data about physical function, social function, activity and frailty. OA-CP dyads will be randomized (1:1) to a physical activity intervention: either EngAGE or usual care. All subjects will be asked to complete exercises 3-6 times per week. Care Partners will be instructed to encourage their Older Adult partner to perform physical activities on a regular basis. There is a two week Run-In Period to troubleshoot the EngAGE app and acclimate the OA subjects to the study intervention. OA subjects will be monitored via phone visits on a monthly basis. In home study visits will take place at month 3 and month 6. Data about OA subject physical function, social function, activity and frailty will be collected at these visits.

Conditions
Frailty
Being tested
Enhanced Engagement, Standard Engagement
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Enhanced EngagementBehavioural

    EngAGE will allow care partners send older adults encouragement which will be read aloud to the older adult through the EngAGE app.

  • Standard EngagementBehavioural

    Care partners can encourage their older adult partner using traditional / existing communication mechanisms.

Study groups in NCT05337514
Study groupRoleWhat they receive
EngAGEExperimentalOlder adult subjects will receive an Alexa Echo Show that runs an exercise app called EngAGE.
Receives: Behavioral: Enhanced Engagement
Physical Exercise HandoutsActive comparatorOlder adults subjects will receive a paper booklet containing exercise instructions.
Receives: Behavioral: Standard Engagement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Timed Chair Stands

    5 repeated chair stands

    Measured: 6 months

Secondary outcomes (5)
  1. Grip Strength

    Dominant grip strength measured with a dynamometer, average of 3 attempts

    Measured: 6 months

  2. Loneliness

    Measured with the 9-item UCLS loneliness scale

    Measured: 6 months

  3. 4 meter usual walk

    Participants walk 4 meters 2 times at their usual pace, fastest of 2 attempts.

    Measured: 6 months

  4. Static Balance Poses

    Participants are asked to hold a side-by-side, semi-tandem and tandem balance pose each for 10 seconds.

    Measured: 6 months

  5. Physical activity

    Wrist accelerometers will be worn for 7 full days in the free living environment.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2022
  2. Study start26 Oct 2022
  3. Primary completion16 Apr 2026
  4. Study completion16 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
137 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05337514
Sponsor's protocol ID
IRB21-1556
Other IDs
P50MD017349
Acronym
EngAGE
Status last verified
Sep 2026
First submitted
13 Apr 2022
Last updated
16 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Enhanced Engagement and Standard Engagement in people with Frailty, run by University of Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Timed Chair Stands (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in